These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2197516)

  • 1. GM-CSF: intravenous versus subcutaneous treatment.
    Aglietta M; Monzeglio C; Piacibello W; Aprá F; Stacchini A; Sanavio F; Mossetti C; Stern AC; Gavosto F
    Leukemia; 1990 Jul; 4(7):523. PubMed ID: 2197516
    [No Abstract]   [Full Text] [Related]  

  • 2. [GM-CSF: granulocyte and macrophage colony stimulating factor. A biologic agent with a great therapeutic potential in oncology].
    Cortes-Funes H
    Rev Clin Esp; 1990 Mar; 186(4):173-4. PubMed ID: 2195605
    [No Abstract]   [Full Text] [Related]  

  • 3. A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion.
    Rifkin RM; Hersh EM; Salmon SE
    Behring Inst Mitt; 1988 Aug; (83):125-33. PubMed ID: 3071327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS file. GM-CSF may boost WBC counts.
    Conover AC
    Am J Nurs; 1990 Apr; 90(4):29. PubMed ID: 2181877
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity study.
    Steward WP; Scarffe JH; Austin R; Bonnem E; Thatcher N; Morgenstern G; Crowther D
    Br J Cancer; 1989 Jan; 59(1):142-5. PubMed ID: 2667607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
    Lieschke GJ; Maher D; O'Connor M; Green M; Sheridan W; Rallings M; Bonnem E; Burgess AW; McGrath K; Fox RM
    Cancer Res; 1990 Feb; 50(3):606-14. PubMed ID: 2404573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GM-CSF with ganciclovir for the treatment of CMV retinitis in AIDS.
    Grossberg HS; Bonnem EM; Buhles WC
    N Engl J Med; 1989 Jun; 320(23):1560. PubMed ID: 2542793
    [No Abstract]   [Full Text] [Related]  

  • 8. Necrotizing vasculitis at granulocyte-macrophage-colony-stimulating factor injection sites.
    Farmer KL; Kurzrock R; Gutterman JU; Duvic M
    Arch Dermatol; 1990 Sep; 126(9):1243-4. PubMed ID: 2204310
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical studies with recombinant human granulocyte-macrophage colony-stimulating factor.
    Steward WP; Scarffe JH; Bonnem E; Crowther D
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():335-46. PubMed ID: 2182743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of recombinant DNA granulocyte macrophage colony stimulating factor.
    Steward WP; Scarffe JH; Austin R; Crowther D
    Behring Inst Mitt; 1988 Aug; (83):324-6. PubMed ID: 3071348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical role of granulocyte-macrophage colony-stimulating factor.
    Mitsuyasu RT; Golde DW
    Hematol Oncol Clin North Am; 1989 Sep; 3(3):411-25. PubMed ID: 2698875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [GM-CSF: its clinical administration; the treatment of aplasia].
    Rossi Ferrini P; Grossi A; Santini V; Vannucchi AM
    Haematologica; 1989 Oct; 74(5 Suppl):489-500. PubMed ID: 2512231
    [No Abstract]   [Full Text] [Related]  

  • 13. Amelioration of chemotherapy-induced thrombocytopenia by GM-CSF: apparent dose and schedule dependency.
    Edmonson JH; Long HJ; Jeffries JA; Buckner JC; Colon-Otero G; Fitch TR
    J Natl Cancer Inst; 1989 Oct; 81(19):1510-2. PubMed ID: 2674462
    [No Abstract]   [Full Text] [Related]  

  • 14. Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials.
    Nissen-Druey C
    Nouv Rev Fr Hematol (1978); 1989; 31(2):99-101. PubMed ID: 2475852
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant human granulocyte-macrophage colony stimulating factor (rh GM-CSF) after bone marrow transplantation.
    Link H; Freund M; Kirchner H; Stoll M; Schmid H; Bucsky P; Seidel J; Schulz G; Schmidt RE; Riehm H
    Behring Inst Mitt; 1988 Aug; (83):313-9. PubMed ID: 3071346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte macrophage colony stimulating factor (GM-CSF) in AIDS.
    Scadden DT
    Prog Clin Biol Res; 1990; 338():163-76. PubMed ID: 2189138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of granulocyte-macrophage colony stimulating factor in patients with HIV infection.
    Mitsuyasu RT; Golde DW
    Behring Inst Mitt; 1988 Aug; (83):139-44. PubMed ID: 3071329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-macrophage colony-stimulating factor: a teaching program for staff and patients.
    Woolery-Antill M
    J Pediatr Oncol Nurs; 1990 Apr; 7(2):61. PubMed ID: 2194506
    [No Abstract]   [Full Text] [Related]  

  • 19. Hematopoietic growth factors: biology and clinical application.
    Gabrilove JL; Jakubowski A
    J Natl Cancer Inst Monogr; 1990; (10):73-7. PubMed ID: 1693284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hematopoietic growth factors in the prevention of infections complications in children with hematologic-oncologic diseases].
    Lehrnbecher T
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A88-102. PubMed ID: 11577368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.